Effects of a digitally enabled cardiac rehabilitation intervention on risk factors, recurrent hospitalization and

Justin Braver1,2,3, Thomas H Marwick1,2, Agus Salim2

  • 1Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.

Insights

Digitally enabled cardiac rehabilitation (DeCR) improved cardiovascular risk factors and reduced hospital days compared to usual care. DeCR outcomes were similar to face-to-face cardiac rehabilitation (F2F-CR), offering a viable alternative for patients.

Area of Science:

  • Cardiology
  • Digital Health
  • Health Services Research

Background:

  • Cardiac rehabilitation (CR) programs are effective but underutilized.
  • Digitally enabled CR (DeCR) offers an alternative delivery model.
  • Assessing DeCR's impact on cardiovascular risk factors and healthcare utilization is crucial.

Purpose of the Study:

  • To evaluate the effectiveness of a DeCR program.
  • To compare DeCR with usual care (UC) and face-to-face CR (F2F-CR).
  • To assess impacts on cardiovascular risk factors and healthcare utilization.

Main Methods:

  • Observational cohort study with propensity score matching.
  • National recruitment of privately insured Australian patients post-cardiac hospitalization.
  • Intervention involved a digital app and weekly telehealth; outcomes compared to UC and F2F-CR.

Main Results:

  • DeCR showed significant improvements in most cardiovascular risk factors.
  • Rehospitalization and mortality rates were similar between DeCR and both UC and F2F-CR groups.
  • DeCR patients had fewer hospital days than UC, with similar utilization to F2F-CR.

Conclusions:

  • DeCR demonstrated lower healthcare utilization than UC, comparable to F2F-CR.
  • DeCR is a suitable and accessible option for post-discharge cardiac patients.
  • Digital CR programs enhance patient choice and access to rehabilitation services.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
929
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
33
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28